Given GLP-1R as the therapeutic target, a structural basis of the GLP-1-GLP-1R interaction is paramount for the design of GLP-1 analogues that fully harness the therapeutic potential of GLP-1R activation
One poll from November 2025 by the nonprofit KFF estimates that 1 in 8 or about 12% of adults report taking a GLP-1 drug to lose weight or treat a chronic condition such as diabetes or heart disease, an increase from 6% in May 2024
Our peptide calculator simplifies these calculations for various concentration and volume requirements
Adult obstructive sleep apnoea
[ Links ] Bonner CM, DeBrie KL, Hug G, Landrigan E, Taylor BJ
The erchen decoction consists of Pinellia ternata, Pericarpium Citri Reticulatae, Poria cocos, and Glycyrrhiza